Beta
Leflunomide
medication Under reviewA disease-modifying antirheumatic drug (DMARD) used to treat rheumatoid arthritis by suppressing the immune system.
Research summary
Scientific evidence from randomized controlled trials and systematic reviews demonstrates leflunomide's efficacy in reducing rheumatoid arthritis symptoms, slowing radiological progression, and improving quality of life measures compared to placebo, with effects comparable to methotrexate and sulfasalazine. No studies were identified involving healthy human subjects, as research focuses exclusively on patients with active rheumatoid arthritis or other conditions. The consensus supports its use in inflammatory arthritis for sustained clinical responses, though long-term safety data emphasize monitoring for adverse effects. Absence of data in healthy populations limits applicability to general wellness or preventive use.
No side effects tracked yet
No side effects have been reported by studies or users for this habit yet.
Research
No studies found yet. Request research to discover relevant studies.
Community updates
No updates yet for this supplement.
Be the first to share your experience!